Literature DB >> 12173577

Long-term efficacy of interferon-alpha in chronic inflammatory demyelinating polyneuropathy.

Giovanni Pavesi, Luigi Cattaneo, Adriana Marbini, Franco Gemignani, Domenico Mancia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12173577     DOI： 10.1007/s00415-002-0693-5

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  16 in total

1.  Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha.

Authors:  M N Meriggioli; J Rowin
Journal:  Muscle Nerve       Date:  2000-03       Impact factor: 3.217

2.  Type I interferons and chronic inflammatory demyelinating polyneuropathy: treatment or cause?

Authors:  R P Lisak
Journal:  Muscle Nerve       Date:  2000-03       Impact factor: 3.217

3.  A randomised double blind trial versus placebo does not confirm the benefit of alpha-interferon in polyneuropathy associated with monoclonal IgM.

Authors:  X Mariette; J C Brouet; S Chevret; J M Leger; P Clavelou; J Pouget; J M Vallat; C Vial
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-08       Impact factor: 10.154

4.  Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-alpha.

Authors:  M E Marzo; M Tintoré; O Fabregues; X Montalbán; A Codina
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-10       Impact factor: 10.154

5.  Treatment of chronic inflammatory demyelinating polyneuropathy with cyclosporin-A.

Authors:  W Mahattanakul; T O Crawford; J W Griffin; J M Goldstein; D R Cornblath
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-02       Impact factor: 10.154

6.  Improvement following interferon beta in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  P P Choudhary; N Thompson; R A Hughes
Journal:  J Neurol       Date:  1995-03       Impact factor: 4.849

7.  Improvement following interferon-alpha 2A in chronic inflammatory demyelinating polyneuropathy.

Authors:  K C Gorson; G Allam; D Simovic; A H Ropper
Journal:  Neurology       Date:  1997-03       Impact factor: 9.910

8.  Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies.

Authors:  I S Martina; P A van Doorn; P I Schmitz; J Meulstee; F G van der Meché
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-02       Impact factor: 10.154

9.  Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  M H Barnett; J D Pollard; L Davies; J G McLeod
Journal:  Muscle Nerve       Date:  1998-04       Impact factor: 3.217

10.  Interferon-alpha may benefit steroid unresponsive chronic inflammatory demyelinating polyneuropathy.

Authors:  M Sabatelli; T Mignogna; G Lippi; M Milone; V Di Lazzaro; P Tonali; E Bertini
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-05       Impact factor: 10.154
View more
  9 in total

Review 1.  Treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  Inna Kleyman; Thomas H Brannagan
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 2.  Chronic inflammatory demyelinating polyneuropathies: current treatment strategies.

Authors:  Thomas B Toothaker; Thomas H Brannagan
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

Review 3.  Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Mohamed Mahdi-Rogers; Ruth Brassington; Angela A Gunn; Pieter A van Doorn; Richard Ac Hughes
Journal:  Cochrane Database Syst Rev       Date:  2017-05-08

Review 4.  Newer therapeutic options for chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Krista Kuitwaard; Pieter A van Doorn
Journal:  Drugs       Date:  2009-05-29       Impact factor: 9.546

5.  Chronic inflammatory demyelinating polyneuropathy.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Curr Treat Options Neurol       Date:  2013-06       Impact factor: 3.598

Review 6.  Multifocal motor neuropathy, multifocal acquired demyelinating sensory and motor neuropathy, and other chronic acquired demyelinating polyneuropathy variants.

Authors:  Mazen M Dimachkie; Richard J Barohn; Jonathan Katz
Journal:  Neurol Clin       Date:  2013-02-16       Impact factor: 3.806

7.  Diagnosis and treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  Eduardo Adonias De Sousa; Thomas H Brannagan
Journal:  Curr Treat Options Neurol       Date:  2006-03       Impact factor: 3.972

8.  Treatment of chronic inflammatory demyelinating polyneuropathy.

Authors:  Eliza E Robertson; Peter D Donofrio
Journal:  Curr Treat Options Neurol       Date:  2010-03       Impact factor: 3.972

Review 9.  Progress in Hematopoietic Stem Cell Transplantation for CIDP.

Authors:  Zhen Qin; Qianyi Huang; Jiangying Zou; Lisha Tang; Zhiping Hu; Xiangqi Tang
Journal:  Int J Med Sci       Date:  2020-01-14       Impact factor: 3.738
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.